BioSpace News Archive

FDA

Abraxis BioScience, Inc. Receives FDA Approval for Caffeine Citrate Injection USP, 20 mg/mL

August 3, 2007
·
1 min read
Drug Development

Bayer HealthCare Pharmaceuticals Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

August 3, 2007
·
1 min read
FDA

Teva Pharmaceutical Industries Limited Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg

August 3, 2007
·
1 min read
Drug Development

ImmunoCellular Therapeutics, Ltd Updates Brain Tumor Vaccine Program Status; First Three Patients Enrolled

August 3, 2007
·
1 min read
Drug Development

Array BioPharma, Inc. Advances ErbB-2 Inhibitor, ARRY-380, into Phase 1 Cancer Patient Trial

August 3, 2007
·
1 min read
Policy

Jazz Pharmaceuticals, Inc. (Jobs) Says Solvay Pharmaceuticals, Inc. Gives FDA More Luvox Information

August 3, 2007
·
3 min read
Business

Accelerator Corporation Venture Capital: Cash for Up to Six Seattle Biotech Startups

August 3, 2007
·
1 min read
Biotech Bay

Shire US Inc. Announces Discontinuation of Ethmozine Tablets

August 3, 2007
·
1 min read
Business

BioDuro, LLC Announces Appointment of Steven M. Hutchins as Vice President, Business Development & Collaboration Management

August 3, 2007
·
1 min read
Drug Development

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)

August 3, 2007
·
1 min read